Pulsenmore Ltd. — Form F-1
Filed July 2, 2026 · analyzed by the Registration Agent
F-1
— Neutral
significance 28/100
What the filing says
Pulsenmore Ltd. (PLSM, Israeli medical device company) filed Form F-1 on July 2, 2026 to register resale of 3,125,000 ordinary shares by Armistice Capital Master Fund Ltd., consisting of 1,562,500 shares from pre-funded warrants (exercise price $0.0001) and 1,562,500 from ordinary warrants (exercise price $4.80). The warrants were issued June 26, 2026 in a private placement that raised ~$7.5M gross proceeds; Armistice paid $4.7999 per combined warrant package. Company receives no proceeds from share resales but may receive ~$7.5M if warrants exercised in cash. As of July 1, 2026, company had 6.5M shares outstanding; stock price $4.93 (Nasdaq).
Why this rating
Resale registration itself is routine; warrant dilution (~48% relative to 6.5M current shares) is material but pricing ($4.80 exercise vs. $4.93 market) suggests investor confidence. Minimal immediate cash impact.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.